Replimune Group, Inc. (REPL)
8.985
-0.48
(-5.12%)
USD |
NASDAQ |
Jun 08, 16:00
8.96
-0.02
(-0.28%)
After-Hours: 20:00
Replimune Group Market Cap : 715.49M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 29.73B |
| Oncolytics Biotech, Inc. | 98.13M |
| Rocket Pharmaceuticals, Inc. | 293.54M |
| Cogent Biosciences, Inc. | 5.321B |
| Lantern Pharma, Inc. | 41.98M |
Market Cap Related Metrics
| PEG Ratio | -0.1797 |
| Price to Book Value | 3.398 |
| Price | 8.985 |
| Earnings Yield | -39.87% |
| PEGY Ratio | -0.1797 |